Every SEC Form 3/4/5 on record for this filer (CIK 1595612) — 4 issuers, 212 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Director | 2025-08-05 → 2026-06-18 | 3 | — |
| WAT | WATERS CORP /DE/ | Director | 2022-11-23 → 2026-02-27 | 7 | — |
| BSX | BOSTON SCIENTIFIC CORP | EVP and CFO | 2016-01-05 → 2025-02-19 | 68 | −$45M |
| NUAN | Nuance Communications, Inc. | Director · lapsed | 2018-09-12 → 2022-03-04 | 6 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| BSX | 2025-02-19 | Sell | 67,333 | $105.24 | $7M | 225,808 |
| BSX | 2025-02-18 | Sell | 14,630 | $104.67 | $2M | 232,618 |
3 of 4 issuers are covered and open a security page; the rest are on file here only.